The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Long-term Survival Following Partial vs Radical Nephrectomy Among Older Patients With Early-Stage Kidney Cancer
Open accessAbstract
CONTEXT: Although partial nephrectomy is the preferred treatment for many patients with early-stage kidney cancer, recent clinical trial data, which demonstrate better survival for patients treated with radical nephrectomy, have generated new uncertainty regarding the comparative effectiveness of these treatment options. OBJECTIVE: To compare long-term survival after partial vs radical nephrectomy among a population-based patient cohort whose treatment reflects contemporary surgical practice. DESIGN, SETTING, AND PATIENTS: We performed a retrospective cohort study of Medicare beneficiaries with clinical stage T1a kidney cancer treated with partial or radical nephrectomy from 1992 through 2007. Using an instrumental variable approach to account for measured and unmeasured differences between treatment groups, we fit a 2-stage residual inclusion model to estimate the treatment effect of partial nephrectomy on long-term survival. MAIN OUTCOME MEASURES: Overall and kidney cancer-specific survival. RESULTS: Among 7138 Medicare beneficiaries with early-stage kidney cancer, we identified 1925 patients (27.0%) treated with partial nephrectomy and 5213 patients (73.0%) treated with radical nephrectomy. During a median follow-up of 62 months, 487 (25.3%) and 2164 (41.5%) patients died following partial or radical nephrectomy, respectively. Kidney cancer was the cause of death for 37 patients (1.9%) treated with partial nephrectomy, and 222 patients (4.3%) treated with radical nephrectomy. Patients treated with partial nephrectomy had a significantly lower risk of death (hazard ratio [HR], 0.54; 95% CI, 0.34-0.85). This corresponded with a predicted survival increase with partial nephrectomy of 5.6 (95% CI, 1.9-9.3), 11.8 (95% CI, 3.9-19.7), and 15.5 (95% CI, 5.0-26.0) percentage points at 2, 5, and 8 years posttreatment (P < .001). No difference was noted in kidney cancer-specific survival (HR, 0.82; 95% CI, 0.19-3.49). CONCLUSION: Among Medicare beneficiaries with early-stage kidney cancer who were candidates for either surgery, treatment with partial rather than radical nephrectomy was associated with improved survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Instrumental Variables Regression with Weak Instruments
Staiger, D., & Stock, J. (1994) · doi:10.3386/t0151 · Cited by 5,302
Guideline for Management of the Clinical T1 Renal Mass
Campbell, S. C., Novick, A. C., Belldegrun, A., Blute, M. L., Chow, G. K., Derweesh, I. H., Faraday, M. M., Kaouk, J. H., Leveillee, R. J., Matin, S. F., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.004 · Cited by 1,831
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling
Terza, J. V., Basu, A., & Rathouz, P. J. (2008) · Journal of Health Economics · doi:10.1016/j.jhealeco.2007.09.009 · Cited by 1,728
Warren, J. L., Klabunde, C. N., Schrag, D., Bach, P. B., & Riley, G. F. (2002) · PubMed · doi:10.1097/01.mlr.0000020942.47004.03 · Cited by 1,714
Huang, W. C., Levey, A. S., Serio, A. M., Snyder, M., Vickers, A. J., Raj, G. V., Scardino, P. T., & Russo, P. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70803-8 · Cited by 1,613
Rising Incidence of Renal Cell Cancer in the United States
Chow, W.-H. (1999) · JAMA · doi:10.1001/jama.281.17.1628 · Cited by 1,586
Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect
Hollingsworth, J. M., Miller, D. C., Daignault, S., & Hollenbeck, B. K. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj362 · Cited by 1,173
Poppel, H. V., Pozzo, L. D., Albrecht, W., Matveev, V., Bono, A., Borkowski, A., Maréchal, J.-M., Klotz, L. H., Skinner, E. C., Keane, T. E., et al. (2006) · European Urology · doi:10.1016/j.eururo.2006.11.013 · Cited by 1,040
Huang, W. C., Elkin, E. B., Levey, A. S., Jang, T. L., & Russo, P. (2009) · Journal of Urology · doi:10.1016/j.juro.2008.09.017 · Cited by 838
Stukel, T. A., Fisher, E. S., Wennberg, D. E., Alter, D. A., Gottlieb, D. J., & Vermeulen, M. J. (2007) · JAMA · doi:10.1001/jama.297.3.278 · Cited by 786
Every Minute Counts When the Renal Hilum Is Clamped During Partial Nephrectomy
Thompson, R. H., Lane, B. R., Lohse, C. M., Leibovich, B. C., Fergany, A., Frank, I., Gill, I. S., Blute, M. L., & Campbell, S. C. (2010) · European Urology · doi:10.1016/j.eururo.2010.05.047 · Cited by 765
Lau, W. K. O., Blute, M. L., Weaver, A. L., Torres, V. E., & Zincke, H. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.12.1236 · Cited by 755
Thompson, R. H., Boorjian, S. A., Lohse, C. M., Leibovich, B. C., Kwon, E. D., Cheville, J. C., & Blute, M. L. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.09.077 · Cited by 713
ECONOMETRICS IN OUTCOMES RESEARCH: The Use of Instrumental Variables
Newhouse, J. P., & McClellan, M. (1998) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.19.1.17 · Cited by 676
The surveillance, epidemiology, and end results program: a national resource.
Hankey, B. F., Ries, L. A. G., & Edwards, B. K. (1999) · PubMed · Cited by 594
Identifying Complications of Care Using Administrative Data
Iezzoni, L. I., Daley, J., Heeren, T., Foley, S. M., Fisher, E. S., Duncan, C., Hughes, J. S., & Coffman, G. A. (1994) · Medical Care · doi:10.1097/00005650-199407000-00004 · Cited by 454
Lane, B. R., Russo, P., Uzzo, R. G., Hernandez, A. V., Boorjian, S. A., Thompson, R. H., Fergany, A. F., Love, T. E., & Campbell, S. C. (2011) · Journal of Urology · doi:10.1016/j.juro.2010.09.131 · Cited by 355
Morrill, R., Cromartie, J., & Hart, G. (1999) · Urban Geography · doi:10.2747/0272-3638.20.8.727 · Cited by 354
Hollenbeck, B. K., Taub, D. A., Miller, D. C., Dunn, R. L., & Wei, J. T. (2006) · Urology · doi:10.1016/j.urology.2005.08.050 · Cited by 338
Radical versus partial nephrectomy: Effect on overall and noncancer mortality
Zini, L., Perrotte, P., Capitanio, U., Jeldres, C., Shariat, S. F., Antebi, E., Saad, F., Patard, J., Montorsi, F., & Karakiewicz, P. I. (2009) · Cancer · doi:10.1002/cncr.24035 · Cited by 315
Weingart, S. N., Iezzoni, L. I., Davis, R. B., Palmer, R. H., Cahalane, M., Hamel, M. B., Mukamal, K., Phillips, R. S., Davies, D. T., & Banks, N. J. (2000) · Medical Care · doi:10.1097/00005650-200008000-00004 · Cited by 289
Renal and cardiovascular morbidity after partial or radical nephrectomy
Miller, D. C., Schonlau, M., Litwin, M. S., Lai, J., & Saigal, C. S. (2008) · Cancer · doi:10.1002/cncr.23218 · Cited by 286
Hollingsworth, J. M., Miller, D. C., Daignault, S., & Hollenbeck, B. K. (2007) · Cancer · doi:10.1002/cncr.22600 · Cited by 275
Bach, P. B., Guadagnoli, E., Schrag, D., Schussler, N., & Warren, J. L. (2002) · Medical Care · doi:10.1097/00005650-200208001-00003 · Cited by 245
Trends in renal tumor surgery delivery within the United States
Dulabon, L. M., Lowrance, W. T., Russo, P., & Huang, W. C. (2010) · Cancer · doi:10.1002/cncr.24965 · Cited by 182
Who is the marginal patient? Understanding instrumental variables estimates of treatment effects.
Harris, K. M., & Remler, D. K. (1998) · PubMed · Cited by 159
Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial
Crawford, E. D., Grubb, R., Black, A., Andriole, G. L., Chen, M.-H., Izmirlian, G., Berg, C. D., & D'Amico, A. V. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5979 · Cited by 159
Terza, J. V., Bradford, W. D., & Dismuke, C. E. (2007) · Health Services Research · doi:10.1111/j.1475-6773.2007.00807.x · Cited by 120
The effect of study arm on prostate cancer treatment in the large screening trial ERSPC
Wolters, T., Roobol, M. J., Steyerberg, E. W., van den Bergh, R. C. N., Bangma, C. H., Hugosson, J., Ciatto, S., Kwiatkowski, M., Villers, A. A., Lujan, M., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24870 · Cited by 99
Treatment Trends for Stage I Renal Cell Carcinoma
Cooperberg, M. R., Mallin, K., Kane, C. J., & Carroll, P. R. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.03.130 · Cited by 96
Complications and Failure to Rescue After Laparoscopic Versus Open Radical Nephrectomy
Tan, H.-J., Wolf, J. S., Ye, Z., Wei, J. T., & Miller, D. C. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.05.074 · Cited by 54
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Motzer, R. J., Jonasch, E., Agarwal, N., Bhayani, S., Bro, W. P., Chang, S. S., Choueiri, T. K., Costello, B. A., Derweesh, I. H., Fishman, M., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0100 · Cited by 571
Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment
Silverman, S. G., Pedrosa, I., Ellis, J. H., Hindman, N. M., Schieda, N., Smith, A. D., Remer, E. M., Shinagare, A. B., Curci, N. E., Raman, S. S., et al. (2019) · Radiology · doi:10.1148/radiol.2019182646 · Cited by 529
Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline
Finelli, A., Ismaila, N., Bro, B., Durack, J., Eggener, S., Evans, A., Gill, I., Graham, D., Huang, W., Jewett, M. A. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.9645 · Cited by 367
MacLennan, S., Imamura, M., Lapitan, M. C., Omar, M. I., Lam, T. B. L., Hilvano-Cabungcal, A. M., Royle, P., Stewart, F., MacLennan, G., MacLennan, S. J., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.07.028 · Cited by 285
Metadata
- Authors
- Norton, E. C.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2012-04-18
- Volume
- 307
- Issue
- 15
- Pages
- 1629
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2130020900
- Cited by
- 417
- References
- 34
- FWCI
- 37.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.